You’ll often hear us use the term “trying to find the next Microsoft” which refers to investors who are looking for that one exciting get-rich-quick stock as opposed to doing it the slow an...
On our first road trip to San Francisco we headed straight to Haight-Ashbury, the birthplace of 1960s counterculture and one of the most iconic landmarks in the city. We were hoping to score some...
There’s a time in our lives when we start going to more funerals than weddings. Friends start complaining about aches and pains. They can’t remember stuff as well as they could. Diseases like...
Nanotechnology was all the rage back in 2004 when George Dubya Bush signed the Nanotechnology Research and Development Act and investors caught wind of a potential opportunity. This, of course, p...
In May of last year, we published an article titled “What if 3D Printing Was 1000X Faster” which talked about a 3D printing company called Carbon 3D which is looking to completely disrupt 3D...
We’ve covered plenty of over-the-counter (OTC) companies in the past and have pointed out many red flags for investors to consider. The fact is that a majority of OTC companies fail and this is...
Graphene is a material with remarkable properties that has attracted the attention of starry-eyed investors who are dreaming up all kinds of potential disruptive applications such as advanced mat...
In September of 2013, we highlighted Nanosphere (NASDAQ:NSPH) and their promises of high margins for a technology which uses gold nanoparticles to develop clinical diagnostic tests that are two t...
In a previous article, we highlighted Nanobiotix (EPA:NANO), a company that saw their share price increase nearly +200% in the past 12 months on the back of their nanoparticles that are injected...
In August of last year, we highlighted a nano drug delivery company called BIND Therapeutics (NASDAQ:BIND), a company with strong pharma partnerships and an experienced management team. While BIN...